HeartLight Pulse Study: Evaluation of Heart Rate Using an Electronic Stethoscope and Pre Placed ECG in the Delivery Room (HLPulseS)

May 11, 2018 updated by: University of Nottingham

Determination of Heart Rate in Neonates on the NICU and Delivery Suite Using ECG and Electronic Stethoscope, a Feasibility Study

This study will evaluate the accuracy of both an electronic stethoscope and electrocardiogram (ECG) to evaluate heart rate in neonatal patients in the delivery suite.

The initial phase of this study will assess the electronic stethoscope use on stable neonates on the neonatal care prior to use in the delivery room.

Study Overview

Detailed Description

Up to 10% of newborns (79K/yr in United Kingdom, 13 million/yr worldwide) require some form of resuscitation at birth. It is estimated that approximately 7 million babies worldwide, especially the premature group, will require more advanced resuscitation. The correct, structured management of the resuscitation in the few 'golden' minutes after birth is critical to prevent significant morbidity (e.g. cerebral palsy due to asphyxiation) or death. There is strong evidence that standardised resuscitation training and algorithms significantly improve newborn outcomes and could reduce mortality by 30% in certain healthcare institution. International newborn resuscitation guidelines state that "a prompt increase in heart rate remains the most sensitive indicator of resuscitation efficacy" and that the stethoscope should be the primary means of assessing heart rate (HR). Provision of an accurate and timely HR value is essential if the best care outcomes are to be achieved. Establishing the HR category allows the resuscitator to decide if the HR is >100 bpm (suggests the baby is well or resuscitation is effective), between 60-100bpm (resuscitation required initially focusing on the airway) or <60bpm (requires much more intensive resuscitation which could include CPR). International guidelines recommend assessing the HR every 30 seconds with a stethoscope to track changes and hence efficacy of resuscitation. However, a number of studies demonstrate that newborn healthcare providers estimate the HR category incorrectly in about 1 in 3 cases, potentially resulting in the incorrect management of the baby. There is now strong evidence linking the need for resuscitation and a poor neurodevelopmental outcome in later childhood. Indeed, a number of large cohort studies have demonstrated that even if a baby requires initial resuscitation, and no further need for on-going care, they are at an increased risk of low intelligence quotient in childhood and are less likely to have paid employment or go to University when adults.

More recently electronic stethoscopes (ES) have been used to determine heart rate variability. Several studies have shown that an ES can reliably evaluate the heart rate in adults, but only one recently published study has demonstrated its use in the neonatal patient. The advantage of using an ES over ECG and pulse oximetry is fast acquisition of HR (<5 sec) and ease of application, both attributes are beneficial in the delivery suite scenario. Furthermore, assessment of HR by auscultation (using a stethoscope) is still the primary technique used in many settings.

ECG, an established and accurate method of monitoring HR, is rarely used in the delivery room for a number of reasons including difficulty ensuring adhesion to the skin (the baby is wet/covered in vernix) and skin damage in premature babies caused by stripping of the electrodes. Current ECG systems also require 3 electrodes to be positioned which can delay resuscitation further. To improve HR assessment at birth we aim to tackle this problem through a variety of means. ECG is not routinely used for delivery room resuscitations mainly due to the impracticalities of attaching the electrodes and setting up the system. Current NICU practice is to place the ECG electrodes onto the baby's chest. It is also possible for the electrodes to be placed on the baby's which is a method commonly adopted on the NICU. Preterm babies are routinely delivered into a plastic bags/wraps to minimise heat loss. By pre-placing the ECG electrodes onto the back of the bag/wrap with small conducting holes in, it should be possible to place the baby onto the bag and connect with the ECG electrodes with a routinely used clinical conducting gel. The baby could be placed onto them and time would be saved by not needing to stick the electrodes on individually and utilising the baby's weight to establish the electrode connections. This would avoid the need to place them individually, which is often time consuming and challenging as they don't still well to wet skin, and avoid skin stripping when removed later.

This study will initially assess the accuracy and reliability of an electronic stethoscopes to evaluate heart rate on stable patients on the neonatal unit compared to routine ECG and pulse oximetry measurements. This will allow comparison of the pre placed ECG system in the second phase of the study.

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nottingham, United Kingdom, NG72UH
        • University of Nottingham NHS Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 4 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Phase 1- neonates of any gestation admitted to NICU with routine ECG and pulse oximetry monitoring

Description

Inclusion Criteria:

  • All must have written informed consent from the participant's mother
  • Phase 1: Any neonate requiring NICU admission and routine monitoring with ECG.
  • Phase 2: Preterm infants ≤32 weeks gestation delivered into a plastic bag/wrap

Exclusion Criteria:

  • Phase 1: Infants undergoing comfort care (palliative care). Infants deemed too sick, as assessed by the clinical team caring for them, to tolerate additional procedures. This is unusual but would normally include infants who become more unstable with increased handling
  • Phase 2: Infants >32 weeks gestation Infants where resuscitation is unlikely to be instigated (eg. known lethal condition)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
NICU electronic stethoscope
Neonatal patients of any gestation admitted to the neonatal intensive care unit (NICU) and undergoing routine monitoring with ECG and pulse oximetry Heart rate will be evaluated using an electronic stethoscope
Assessment of heart rate using the electronic stethoscope for up to 10 minutes compared to ECG and pulse oximetry devices used to monitor neonates whilst on NICU
Newborns <32 weeks and ECG
Neonatal patients <32 weeks gestation Heart rate will be assessed at the time of delivery with both an electronic stethoscope and ECG using a pre placed lead system
Assessment of heart rate using the electronic stethoscope for up to 10 minutes compared to ECG and pulse oximetry devices used to monitor neonates whilst on NICU
The three leads from the ECG device will be pre placed onto a plastic bag prior to delivery. The pre term infant (<32 weeks) placed into the bag at the time of delivery and heart rate will be assessed for up to 30 minutes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate
Time Frame: 10 minutes
Assessment of accuracy (limits of agreement ±10bpm at 2 standard deviations) and reliability (>90% agreement +/- 10 bpm) of an electronic stethoscope to measure heart rate when compared to ECG.
10 minutes
Reliability of Pre placed ECG leads to measure heart rate
Time Frame: 30 minutes
Assess of the reliability of pre-placed ECG to measure heart rate at the time of delivery when compared to heart rate assessed by an electronic stethoscope.
30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of Clinical assessment of heart rate using an electronic stethoscope
Time Frame: 30 minutes
Evaluation of the heart rate by the clinical team when using the electronic stethoscope by subjective counting compared to actual detection of heart rate (computed by software)
30 minutes
Acquisition of video recorded resuscitation of newborns for clinical feedback
Time Frame: 30 minutes
The resuscitation of the neonate in the delivery room will be recorded to allow alignment of data (i.e. time baby placed in bag, time electronic stethoscope used). This video will be used as a resuscitation training tool for training clinicians.
30 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Don Sharkey, PhD, University of Nottingham

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

February 25, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimate)

April 21, 2016

Study Record Updates

Last Update Posted (Actual)

May 17, 2018

Last Update Submitted That Met QC Criteria

May 11, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premature Birth

Clinical Trials on NICU electronic stethoscope

3
Subscribe